D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Other Receivables Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Other Receivables
myr21.7m
CAGR 3-Years
89%
CAGR 5-Years
34%
CAGR 10-Years
21%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Other Receivables
myr7.7m
CAGR 3-Years
63%
CAGR 5-Years
62%
CAGR 10-Years
34%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Other Receivables
myr45.8k
CAGR 3-Years
-67%
CAGR 5-Years
-59%
CAGR 10-Years
-19%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Other Receivables
myr494k
CAGR 3-Years
70%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Other Receivables
myr1.6m
CAGR 3-Years
-58%
CAGR 5-Years
-41%
CAGR 10-Years
-19%
K
Kotra Industries Bhd
KLSE:KOTRA
Other Receivables
myr2.7m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
0%

See Also

What is Duopharma Biotech Bhd's Other Receivables?
Other Receivables
21.7m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Other Receivables amounts to 21.7m MYR.

What is Duopharma Biotech Bhd's Other Receivables growth rate?
Other Receivables CAGR 10Y
21%

Over the last year, the Other Receivables growth was 175%. The average annual Other Receivables growth rates for Duopharma Biotech Bhd have been 89% over the past three years , 34% over the past five years , and 21% over the past ten years .

Back to Top